Skip to content
Back to Investors
MS

Morgan Stanley

Venture Capital

Morgan Stanley Investment Management provides investment management solutions globally and manages the 1GT climate private equity strategy focusing on decarbonisation solutions.

Portfolio

7

companies

Investment by month

By category

  • FinTech£129M
  • AI/ML£27.0M
  • ConstructionTech£2.6M
  • AdTech£2.5M
  • eCommerce£1.3M

By location

  • London£158M
  • Coventry£2.6M
  • United Kingdom£1.3M

Portfolio companies

Automated Architecture

Automated Architecture

Automated Architecture uses robotics and artificial intelligence to help homebuilders cut construction costs.

IA

Inicio AI

Inicio AI provides conversational artificial intelligence solutions for customer affordability assessments.

M

MyARC

MyARC builds an operating system for fitness creators to scale coaching and monetisation.

Thought Machine

Thought Machine

Thought Machine develops cloud native core banking technology for financial institutions.

U

Unfabled

Unfabled is a women's health platform offering supplements designed for female wellness.

Vyntelligence

Vyntelligence

Vyntelligence provides an agentic video intelligence platform that simplifies and accelerates frontline field work.

View all 7 companies

Team

Sanghamitra Karra

Sanghamitra Karra

Managing Director and EMEA Head of the Morgan Stanley Inclusive Ventures Group

Sanghamitra serves as Global Co-Head of Inclusive and Sustainable Ventures at Morgan Stanley, following roles leading the firm's Inclusive Ventures Group in EMEA.

LinkedIn
Jake Van Koevering

Jake Van Koevering

Partner

Jake is a partner at Morgan Stanley, focusing on climate investing. He also holds board and observer roles across several companies.

LinkedIn

Recent investments

Seed
£1.5M

The investment round was backed by Araya Ventures, Morgan Stanley, Techstars and G Fund to fuel platform innovation and global growth.

"MyARC was built for modern day fitness creators, giving them the tools they need to grow without burning out. The traditional online fitness model has left creators trapped between low-value generic products and unsustainable personal coaching. With this platform, they can scale their impact and income without sacrificing quality."
— Peter Monteza, Founder and CEO
Series B
£22.9M

The Series B round was co-led by Blume Equity and Morgan Stanley Investment Management to fund expansion into the United States.

"This partnership with Blume Equity and Morgan Stanley Investment Management’s 1GT validates our mission to transform how field work is captured, analysed, and acted upon. With this investment, we will expand our platform capabilities and geographic footprint, including the US, and continue building the world’s most comprehensive frontline work solutions that drive intelligent collaboration and value creation across the entire ecosystem and supply chain."
— Kapil Singhal, Co founder and CEO
Seed
£2.6M

The funding round was backed by Midven, Rigby Group, and Haatch Ventures.

"This investment, coupled with our success in the OneToWin competition, marks a significant milestone in our mission to revolutionise affordability assessments. With this funding, we can expand our team, enhance our technology, and bring our innovative solutions to a wider market. It’s hugely rewarding to be able to improve the financial well-being of individuals whilst also increasing efficiency for creditors."
— Rachel Curtis, CEO
Seed
£2.6M

The seed round was led by Miles Ahead to support the expansion of the company partner license network and US operations.

"AUAR has developed all the tech home builders need to develop, produce, and build affordable low-energy homes while increasing margins and productivity. Our technology is low CapEx, doesn’t require big factories, and pays itself back in a few months."
— Gilles Retsin, Co-Founder and CTO
Seed
£1.3M

Morgan Stanley led the seed round to support platform expansion and data science development.

"Despite 90% of the UK’s 33.8 million female population experiencing monthly hormonal symptoms, women’s health has for too long been fragmented and underserved. Unfabled has already empowered thousands of women to find effective treatments for common, yet hugely disruptive, hormonal and reproductive conditions like PMS, Polycystic Ovary Syndrome (PCOS), endometriosis and menopause."
— Hannah Samano, Founder